Neuromidin is a prescription injectable medicine containing Ipidacrine, a cholinesterase inhibitor used in neurology to improve neuromuscular transmission and support the recovery of peripheral and central nervous system function.
The medicine is supplied as a sterile solution for intramuscular (IM) and subcutaneous (SC) administration and is available in two strengths:
Manufactured by OlainFarm (Latvia), Neuromidin is widely used in neurological practice under medical supervision.
Suitable when a lower concentration or gradual dose adjustment is required.
Used when a higher concentration is prescribed by a healthcare professional.
Ipidacrine inhibits cholinesterase, increasing acetylcholine availability and enhancing impulse transmission across peripheral nerves and neuromuscular junctions.
It helps support:
Neuromidin may be prescribed for:
Neuromidin should only be used as prescribed by a physician.
The dosage and duration of treatment are determined individually based on the patient's condition and therapeutic response.
Some patients may experience:
Medical advice should be sought if severe or persistent adverse effects occur.
Neuromidin should not be used in patients with:
Store according to the manufacturer's recommendations.
Keep out of reach of children.
Do not use after the expiration date.
Both products contain ipidacrine. The difference is the concentration of the active ingredient, and the appropriate strength is selected by the prescribing physician.
Neuromidin is prescribed for neurological conditions involving impaired nerve conduction and neuromuscular transmission.
Injections should be administered by a qualified healthcare professional or as directed by your physician.
Yes. Neuromidin is manufactured by OlainFarm, Latvia.
Both strengths are supplied in packs containing 10 ampoules of 1 ml each.
